Core Laboratories (CLB) Shares Bought by Millennium Management LLC

Millennium Management LLC lifted its stake in Core Laboratories (NYSE:CLB) by 9,329.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 226,594 shares of the oil and gas company’s stock after buying an additional 224,191 shares during the quarter. Millennium Management LLC’s holdings in Core Laboratories were worth $28,598,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its holdings in shares of Core Laboratories by 3.8% in the second quarter. BlackRock Inc. now owns 3,186,363 shares of the oil and gas company’s stock worth $402,151,000 after buying an additional 117,678 shares in the last quarter. Epoch Investment Partners Inc. raised its stake in Core Laboratories by 12.5% during the first quarter. Epoch Investment Partners Inc. now owns 1,201,833 shares of the oil and gas company’s stock valued at $130,062,000 after purchasing an additional 133,833 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Core Laboratories by 9.3% during the first quarter. JPMorgan Chase & Co. now owns 1,179,431 shares of the oil and gas company’s stock valued at $127,640,000 after purchasing an additional 100,435 shares in the last quarter. Sei Investments Co. raised its stake in Core Laboratories by 40.1% during the first quarter. Sei Investments Co. now owns 638,723 shares of the oil and gas company’s stock valued at $69,123,000 after purchasing an additional 182,848 shares in the last quarter. Finally, Northern Trust Corp raised its stake in Core Laboratories by 2.5% during the first quarter. Northern Trust Corp now owns 474,666 shares of the oil and gas company’s stock valued at $51,368,000 after purchasing an additional 11,777 shares in the last quarter.

Core Laboratories stock opened at $112.42 on Tuesday. The firm has a market cap of $4.91 billion, a P/E ratio of 50.01, a price-to-earnings-growth ratio of 3.80 and a beta of 1.50. The company has a current ratio of 2.24, a quick ratio of 1.85 and a debt-to-equity ratio of 1.53. Core Laboratories has a 52-week low of $87.66 and a 52-week high of $130.34.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 25th. The oil and gas company reported $0.59 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.59. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The business had revenue of $175.48 million for the quarter, compared to analysts’ expectations of $174.47 million. During the same quarter in the previous year, the business posted $0.51 earnings per share. The business’s revenue was up 10.9% compared to the same quarter last year. equities research analysts predict that Core Laboratories will post 2.44 earnings per share for the current fiscal year.

A number of equities research analysts recently issued reports on CLB shares. ValuEngine downgraded shares of Core Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, June 6th. ABN Amro downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, July 2nd. Citigroup downgraded shares of Core Laboratories from a “neutral” rating to a “sell” rating in a research note on Monday, July 2nd. Zacks Investment Research downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, July 4th. Finally, Royal Bank of Canada decreased their price target on shares of Core Laboratories to $130.00 and set an “outperform” rating on the stock in a research note on Thursday, July 5th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the stock. Core Laboratories currently has an average rating of “Hold” and an average target price of $116.00.

About Core Laboratories

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Recommended Story: Technical Analysis

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply